GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | 8/14/2026 4:21:50 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $11,802,000 | EPS -$0.10 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/14/2026 11:15:08 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $11,802,000 | EPS -$0.10 | ||
| Jasper Therapeutics, Inc. (JSPR) | 6/15/2026 4:04:40 PM | View | Proxy | SEC | Y 2025 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 5/14/2026 4:16:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $21,184,000 | EPS -$0.04 | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/14/2026 4:07:40 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $21,184,000 | EPS -$0.04 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 4/30/2026 4:16:47 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $35,779,000 | EPS -$3.95 | ||
| Jasper Therapeutics, Inc. (JSPR) | 3/30/2026 6:26:35 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $35,779,000 | EPS $0.23 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 3/30/2026 5:45:24 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $35,779,000 | EPS -$3.95 | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/10/2025 8:22:28 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $57,469,000 | EPS -$1.13 | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/10/2025 8:06:09 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $57,469,000 | EPS -$1.13 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/13/2025 4:13:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $46,466,000 | EPS -$1.74 | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/13/2025 4:12:35 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $46,466,000 | EPS -$1.74 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/19/2025 8:02:10 AM | View | Proxy | SEC | Y 2024 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2025 4:13:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $57,597,000 | EPS -$1.41 | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2025 4:05:57 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $57,597,000 | EPS -$1.41 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 2/28/2025 9:32:31 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $79,899,000 | EPS -$4.89 | ||
| Jasper Therapeutics, Inc. (JSPR) | 2/27/2025 8:06:31 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $79,899,000 | EPS -$1.64 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/7/2024 7:43:06 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $99,413,000 | EPS -$1.24 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/7/2024 7:41:11 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $99,413,000 | EPS -$1.24 | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/13/2024 7:17:49 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $113,929,000 | EPS -$0.97 | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/13/2024 7:02:26 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Assets $113,929,000 | EPS -$0.97 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/14/2024 2:07:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $125,963,000 | EPS -$1.03 | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/14/2024 8:03:41 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $125,963,000 | EPS -$1.03 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 4/22/2024 1:15:05 PM | View | Proxy | SEC | Y 2023 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 3/5/2024 4:20:44 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $94,892,000 | EPS -$6.18 | ||
| Jasper Therapeutics, Inc. (JSPR) | 3/4/2024 7:41:36 AM | View | Financials | Earnings | SEC | Y 2023 | Rev ($118,000) | Assets $94,892,000 | EPS -$5.71 | Export Earnings Model | |
| Jasper Therapeutics, Inc. (JSPR) | 11/20/2023 5:13:04 PM | View | Proxy | SEC | Y 2022 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 11/9/2023 9:28:37 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $51,000 -81.0% | Assets $110,405,000 | EPS -$0.16 | |
| Jasper Therapeutics, Inc. (JSPR) | 11/9/2023 8:06:49 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $51,000 -81.0% | Assets $110,405,000 | EPS -$0.16 | Export Earnings Model | |
| Jasper Therapeutics, Inc. (JSPR) | 8/11/2023 4:15:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $124,170,000 | EPS -$0.15 | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/11/2023 4:06:34 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev ($109,000) | Assets $124,170,000 | EPS -$0.15 | Export Earnings Model | |
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2023 4:23:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $138,757,000 | EPS -$0.16 | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2023 4:06:11 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev ($70,000) | Assets $138,757,000 | EPS -$0.16 | Export Earnings Model | |
| Jasper Therapeutics, Inc. (JSPR) | 4/21/2023 4:02:56 PM | View | Proxy | SEC | Y 2022 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 3/8/2023 4:17:31 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $48,361,000 | EPS -$1.03 | ||
| Jasper Therapeutics, Inc. (JSPR) | 3/8/2023 4:06:47 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $48,361,000 | EPS -$0.36 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/10/2022 4:27:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $268,000 | Assets $59,110,000 | EPS -$0.32 | |
| Jasper Therapeutics, Inc. (JSPR) | 11/10/2022 4:09:51 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $268,000 | Assets $59,110,000 | EPS -$0.32 | Export Earnings Model | |
| Jasper Therapeutics, Inc. (JSPR) | 8/12/2022 4:21:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $89,000 +2,125.0% | Assets $70,366,000 | ||
| Jasper Therapeutics, Inc. (JSPR) | 8/12/2022 4:03:20 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $89,000 +2,125.0% | Assets $70,366,000 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2022 4:28:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $80,548,000 | |||
| Jasper Therapeutics, Inc. (JSPR) | 5/12/2022 4:07:27 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev ($72,000) | Assets $80,548,000 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 4/29/2022 4:03:17 PM | View | Proxy | SEC | Y 2021 | ||||||
| Jasper Therapeutics, Inc. (JSPR) | 3/18/2022 4:24:05 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $93,654,000 | EPS -$2.69 | ||
| Jasper Therapeutics, Inc. (JSPR) | 3/18/2022 4:09:59 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $93,654,000 | EPS $4.44 | Export Earnings Model | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/12/2021 4:15:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $107,213,000 | EPS -$0.69 | ||
| Jasper Therapeutics, Inc. (JSPR) | 11/12/2021 4:03:38 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev ($9,000) | Assets $107,213,000 | EPS -$0.69 | Export Earnings Model | |
| Amplitude Healthcare Acquisition Corp (JSPR) | 8/16/2021 5:12:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $4,000 | Assets $100,549,035 | ||
| Amplitude Healthcare Acquisition Corp (JSPR) | 5/24/2021 4:35:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,000 | Assets $100,960,410 | ||
| Amplitude Healthcare Acquisition Corp (JSPR) | 5/24/2021 4:25:41 PM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Assets $23,357,000 | EPS -$5.17 | ||
| Amplitude Healthcare Acquisition Corp (JSPR) | 3/30/2021 5:35:56 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $23,357,000 | EPS -$5.17 | ||
| Amplitude Healthcare Acquisition Corp (JSPR) | 12/4/2020 5:21:12 PM | View | Proxy | SEC | Y 2019 | ||||||
| Amplitude Healthcare Acquisition Corp (JSPR) | 11/10/2020 5:33:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | ||||
| Amplitude Healthcare Acquisition Corp (JSPR) | 8/14/2020 6:13:01 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | ||||
| Amplitude Healthcare Acquisition Corp (JSPR) | 5/13/2020 5:24:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | ||||
| Amplitude Healthcare Acquisition Corp (JSPR) | 3/26/2020 4:22:15 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 |